Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease

被引：67
|
作者：
Salama, Hosny [2 ]
Zekri, Abdel-Rahman N. [1 ]
Bahnassy, Abeer A. [3 ]
Medhat, Eman [2 ]
Halim, Hanan A. [2 ]
Ahmed, Ola S. [1 ]
Mohamed, Ghada [2 ]
Al Alim, Sheren A. [2 ]
Sherif, Ghada M. [4 ]
机构：
[1] Cairo Univ, Virol & Immunol Unit, Dept Canc Biol, Natl Canc Inst, Cairo 11976, Egypt
[2] El Kasr Al Aini Sch Med, Dept Trop Med, Cairo 11977, Egypt
[3] Cairo Univ, Dept Pathol, Natl Canc Inst, Cairo 11976, Egypt
[4] Cairo Univ, Biostat & Epidemiol Dept, Natl Canc Inst, Cairo 11976, Egypt
来源：
WORLD JOURNAL OF GASTROENTEROLOGY | 2010年 / 16卷 / 42期
关键词：
CD34; CD133; Stem cell; Liver; Hepatitis C virus; BONE-MARROW-CELLS; STROMAL CELLS; INFUSION; DIFFERENTIATE; INJECTION; CIRRHOSIS; MUSCLE; BRAINS; BLOOD; MICE;
D O I：
10.3748/wjg.v16.i42.5297
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
AIM: To assess the utility of an autologous CD34(+) and CD133(+) stem cells infusion as a possible therapeutic modality in patients with end-stage liver diseases. METHODS: One hundred and forty patients with end-stage liver diseases were randomized into two groups. Group 1, comprising 90 patients, received granulocyte colony stimulating factor for fiVE days followed by autologous CD34(+) and CD133(+) stem cell infusion in the portal vein. Group 2, comprising 50 patients, received regular liver treatment only and served as a control group. RESULTS: Near normalization of liver enzymes and improvement in synthetic function were observed in 54.5% of the group 1 patients; 13.6% of the patients showed stable states in the infused group. None of the patients in the control group showed improvement. No adverse effects were noted. CONCLUSION: Our data showed that a CD34(+) and CD133(+) stem cells infusion can be used as supportive treatment for end-stage liver disease with satisfactory tolerability. (C) 2010 Baishideng. All rights reserved.
引用
收藏
页码：5297 / 5305
页数：9
相关论文
共 50 条
  • [21] Differential gene expression of cord blood-derived CD34+ and CD133+ cells
    Hemmoranta, H.
    Hautaniemi, S.
    Niemi, J.
    Nicorici, D.
    Laine, J.
    Yli-Harja, O.
    Partanen, J.
    Jaatinen, T.
    EXPERIMENTAL HEMATOLOGY, 2006, 34 (09) : 70 - 70
  • [22] Influence of regeneration of heart muscle by intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction on Mobilization of CD34+ and CD133+ circulating progenitor cells
    Turan, R. G.
    Brehm, M.
    Koestering, M.
    Zeus, T.
    Bartsch, T.
    Steiner, S.
    Schannwell, C. M.
    Strauer, B. E.
    EUROPEAN JOURNAL OF HEART FAILURE, 2007, 6 : 96 - 96
  • [23] CD133+ and CD133- Cancer stem cells in glioblastoma
    Beier, D.
    Hau, P.
    Proescholdt, M.
    Lohmeier, A.
    Aigner, L.
    Brawanski, A.
    Bogdahn, U.
    Beier, C. P.
    NEURO-ONCOLOGY, 2006, 8 (04) : 317 - 317
  • [24] CHARACTERIZATION AND IMAGING OF CD133+ LIVER CANCER STEM CELLS
    Suetsugu, A.
    Osawa, Y.
    Aoki, H.
    Kunisada, T.
    Tsurumi, H.
    Hoffman, R. M.
    Moriwaki, H.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S445 - S446
  • [25] MicroRNAs as Markers for Neurally Committed CD133+/CD34+ Stem Cells Derived from Human Umbilical Cord Blood
    Maryam Hafizi
    Amir Atashi
    Behnaz Bakhshandeh
    Mahboubeh Kabiri
    Samad Nadri
    Reza Haji Hosseini
    Masoud Soleimani
    Biochemical Genetics, 2013, 51 : 175 - 188
  • [26] Autologous CD34+ selected peripheral stem cell transplantation (ASCT/CD34+) for multiple sclerosis (MS).
    Carreras, E
    Saiz, A
    Graus, F
    Marín, P
    Urbano-Ispizua, A
    Mercader, JM
    Martínez, C
    Rovira, M
    Mazzara, R
    Merino, A
    Tolosa, E
    Montserrat, E
    BONE MARROW TRANSPLANTATION, 1999, 23 : S33 - S33
  • [27] Factors influencing spontaneous mobilization of CD34+ and CD133+ progenitor cells after myocardial infarction
    Turan, R. G.
    Brehm, M.
    Koestering, M.
    Tobias, Z.
    Bartsch, T.
    Steiner, S.
    Picard, F.
    Ebner, P.
    Schannwell, C. M.
    Strauer, B. E.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2007, 37 (11) : 842 - 851
  • [28] Pilot study of selection and transplantation of autologous highly purified CD133+ stem cells in chronic lymphocytic leukemia patients with advanced disease
    Isidori, A.
    Motta, M. R.
    Tani, M.
    Terragna, C.
    Sinzani, P.
    Curti, A.
    Rizzi, S.
    Taioli, S.
    Giudice, V
    D'Addio, A.
    Gugliotta, G.
    Conte, R.
    Baccarani, M.
    Lemoli, R. M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 13 - 13
  • [29] CD34+ and CD133+ Primitive Stem Cell Expression in Peripheral Blood: Considering Gender, Age, and Smoking
    Reichelt, Heike
    Barz, Dagmar
    Thude, Hansjoerg
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2009, 36 (02) : 129 - 134
  • [30] SELECTION AND TRANSPLANTATION OF AUTOLOGOUS CD34+ STEM-CELLS IN PATIENTS WITH NON-HODGKINS-LYMPHOMAS
    DOUAY, L
    LAPORTE, JP
    LOPEZ, M
    QUITTET, P
    LESAGE, S
    MOREL, P
    ISNARD, F
    LEMOINE, F
    STACHOWIAK, J
    GRANDE, M
    NAIMAN, A
    GORIN, NC
    EXPERIMENTAL HEMATOLOGY, 1994, 22 (08) : 774 - 774
12345